Calcilytix , a BridgeBio company, is enrolling people ages 16 years or older into their phase 3 clinical study CALIBRATE.

September 26, 2023

clinicaltrials.gov/study/NCT05680818?cond=Hypoparathyroidism&intr=calibrate&rank=1

 

 

Back to News